Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 9, 2017 – The FDA approved an update to the Warnings and Precautions section of the Lysodren (mitotane) drug label, regarding ovarian macrocysts in premenopausal women.
Return to publications